Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 22:57:35 UTC
Update Date2021-09-26 23:17:49 UTC
HMDB IDHMDB0259953
Secondary Accession NumbersNone
Metabolite Identification
Common Name6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione
Description6-(1H-imidazol-1-yl)-7-nitro-1,2,3,4-tetrahydroquinoxaline-2,3-dione belongs to the class of organic compounds known as quinoxalines. Quinoxalines are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring. Based on a literature review very few articles have been published on 6-(1H-imidazol-1-yl)-7-nitro-1,2,3,4-tetrahydroquinoxaline-2,3-dione. This compound has been identified in human blood as reported by (PMID: 31557052 ). 6-imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedioneMeSH
YM 90KMeSH
YM-90KMeSH
YM90KMeSH
Chemical FormulaC11H7N5O4
Average Molecular Weight273.208
Monoisotopic Molecular Weight273.049803725
IUPAC Name6-(1H-imidazol-1-yl)-7-nitro-1,2,3,4-tetrahydroquinoxaline-2,3-dione
Traditional Name6-(imidazol-1-yl)-7-nitro-1,4-dihydroquinoxaline-2,3-dione
CAS Registry NumberNot Available
SMILES
[O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)N1C=CN=C1
InChI Identifier
InChI=1S/C11H7N5O4/c17-10-11(18)14-7-4-9(16(19)20)8(3-6(7)13-10)15-2-1-12-5-15/h1-5H,(H,13,17)(H,14,18)
InChI KeyGBWIZNYOJITVFI-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as quinoxalines. Quinoxalines are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassDiazanaphthalenes
Sub ClassBenzodiazines
Direct ParentQuinoxalines
Alternative Parents
Substituents
  • Quinoxaline
  • Nitroaromatic compound
  • N-substituted imidazole
  • Pyrazine
  • Benzenoid
  • Azole
  • Imidazole
  • Heteroaromatic compound
  • Lactam
  • C-nitro compound
  • Organic nitro compound
  • Azacycle
  • Organic oxoazanium
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Allyl-type 1,3-dipolar organic compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organic nitrogen compound
  • Organic salt
  • Organic oxygen compound
  • Organic zwitterion
  • Organic oxide
  • Hydrocarbon derivative
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP0.58ALOGPS
logP0.33ChemAxon
logS-2.3ALOGPS
pKa (Strongest Acidic)9.89ChemAxon
pKa (Strongest Basic)6.4ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area119.16 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity79.2 m³·mol⁻¹ChemAxon
Polarizability24.21 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M+H]+157.96932859911
AllCCS[M+H-H2O]+154.29732859911
AllCCS[M+Na]+162.35832859911
AllCCS[M+NH4]+161.37832859911
AllCCS[M-H]-157.7232859911
AllCCS[M+Na-2H]-156.85332859911
AllCCS[M+HCOO]-156.00932859911
DeepCCS[M+H]+157.85230932474
DeepCCS[M-H]-155.49430932474
DeepCCS[M-2H]-189.52330932474
DeepCCS[M+Na]+164.7530932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione[O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)N1C=CN=C13614.7Standard polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione[O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)N1C=CN=C12736.2Standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione[O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)N1C=CN=C13306.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TMS,isomer #1C[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C212790.4Semi standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TMS,isomer #1C[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C212960.7Standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TMS,isomer #1C[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C213968.6Standard polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TMS,isomer #2C[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC(N3C=CN=C3)=C([N+](=O)[O-])C=C212772.2Semi standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TMS,isomer #2C[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC(N3C=CN=C3)=C([N+](=O)[O-])C=C212954.4Standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TMS,isomer #2C[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC(N3C=CN=C3)=C([N+](=O)[O-])C=C213953.2Standard polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,2TMS,isomer #1C[Si](C)(C)N1C(=O)C(=O)N([Si](C)(C)C)C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C212836.2Semi standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,2TMS,isomer #1C[Si](C)(C)N1C(=O)C(=O)N([Si](C)(C)C)C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C213077.2Standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,2TMS,isomer #1C[Si](C)(C)N1C(=O)C(=O)N([Si](C)(C)C)C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C213525.4Standard polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C212943.6Semi standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C213164.2Standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C213935.2Standard polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC(N3C=CN=C3)=C([N+](=O)[O-])C=C212934.8Semi standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC(N3C=CN=C3)=C([N+](=O)[O-])C=C213156.8Standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC(N3C=CN=C3)=C([N+](=O)[O-])C=C213924.7Standard polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)C(=O)N([Si](C)(C)C(C)(C)C)C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C213153.6Semi standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)C(=O)N([Si](C)(C)C(C)(C)C)C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C213493.7Standard non polar33892256
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)C(=O)N([Si](C)(C)C(C)(C)C)C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C213540.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione GC-MS (Non-derivatized) - 70eV, Positivesplash10-0gc1-2190000000-5208b8474823cf64b3582021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID4588960
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound5486548
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]